Standout Papers

Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in ... 2005 2026 2012 2019 646
  1. Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study (2005)
    Barbara Burtness, Meredith A. Goldwasser et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 55 standout
Sub-graph 1 of 20

Citing Papers

Head and neck cancer
2021 Standout
Head and Neck Cancer
2020 Standout
15 intermediate papers

Works of William A. Flood being referenced

Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study
2005 Standout
Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.
1999

Author Peers

Author Last Decade Papers Cites
William A. Flood 451 91 355 319 21 887
Kristen B. Pytynia 298 6 180 559 40 1.0k
Andrew W. Smith 73 35 382 146 35 776
Yu-Leung Chan 159 7 197 224 24 961
Rangesh Kunnavakkam 242 3 407 198 29 775
Sujata M. Patil 332 4 169 106 21 969
Jason Lenox 314 2 218 601 14 868
Sharon L. Collins 178 6 358 339 23 860
Ronald C. Inglehart 278 8 102 85 18 885
Rebecca M.W. Yeung 463 2 485 513 34 1.1k
Vincent Lai 123 4 135 190 42 968

All Works

Loading papers...

Rankless by CCL
2026